MAP4K3 and non-small cell lung carcinoma: Moreover, the GLK-High patients showed a higher risk for recurrence (relative risk, 2.20, 95% confidence interval (CI), 1.157–4.183) than the GLK-Low patients (Table 1), suggesting that GLK overexpression may be a risk factor of recurrence for NSCLC.